CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-06 | Prasad Raju Chief Financial Officer | Option exercise 10b5-1 | +23,361 | $45.15 | $1.1M | 30,128 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Option exercise 10b5-1 | +6,339 | $44.31 | $281K | 36,467 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −18,933 | $60.18 | $1.1M | 17,534 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −5,004 | $60.00 | $300K | 12,530 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −5,763 | $60.21 | $347K | 6,767 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,361 | 76,639 | ||
| 2026-01-06 | Prasad Raju Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,339 | 7,493 | ||
| 2025-12-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −3,528 | $55.10 | $194K | 13,239 |
| 2025-12-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −5,472 | $56.33 | $308K | 7,767 |
| 2025-12-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −1,000 | $56.89 | $57K | 6,767 |
| 2025-12-18 | Kulkarni Samarth Chief Executive Officer | Gift | −30,000 | 224,201 | ||
| 2025-10-17 | Kulkarni Samarth Chief Executive Officer | Sale | −50,895 | $67.91 | $3.5M | 254,201 |
| 2025-10-16 | Kulkarni Samarth Chief Executive Officer | Option exercise | +100,000 | 305,096 | ||
| 2025-10-16 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −100,000 | 300,000 | ||
| 2025-10-14 | Kulkarni Samarth Chief Executive Officer | Sale | −4,242 | $66.60 | $283K | 205,096 |
| 2025-10-14 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,076 | $66.60 | $72K | 83,402 |
| 2025-10-13 | Kulkarni Samarth Chief Executive Officer | Option exercise | +8,334 | 209,338 | ||
| 2025-10-13 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −8,334 | 8,333 | ||
| 2025-10-13 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +2,114 | 84,478 | ||
| 2025-10-13 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −2,114 | 2,113 |
Page 6 of 46 · 910 trades